HitGen Discovery Projects
Currently HitGen has more than 20 projects in research, with 1 in Phase I, 2 in PCC generation and 2 in lead generation.
Therapeutic Areas
Focused on major diseases such as oncology, cardiovascular, inflammation/respiratory, metabolism and others.
Challenging Targets
Most of the project targets are fairly challenging, including PPI targets, dioxygenase targets, dehydrogenase targets, kinase targets and so on.